MASI Sep 2023 150.000 call
| Previous close | 41.70 |
| Open | 39.70 |
| Bid | 40.50 |
| Ask | 44.80 |
| Strike | 150.00 |
| Expiry date | 2023-09-15 |
| Day's range | 39.70 - 41.70 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Business WireMasimo Announces FDA 510(k) Clearance of Radius VSM™
IRVINE, Calif., June 05, 2023--Masimo Radius VSM™, a patient-worn, continuous multi-parameter vital signs monitor, has received FDA 510(k) clearance.
Business WireCORRECTING and REPLACING Masimo Board of Directors Authorizes Appointment of Michelle Brennan as Sixth Director Pending Stockholder Approval of Board Expansion and Election of Company Nominees
IRVINE, Calif., June 02, 2023--On June 2, 2023, Masimo Corporation ("Masimo") issued the following press release in connection with Masimo’s 2023 Annual Meeting of Stockholders, which corrects Masimo’s press release issued earlier on June 2, 2023 (the "Prior Release").
Simply Wall St.Founder of Masimo Joseph Kiani Buys More Stock \
Those following along with Masimo Corporation ( NASDAQ:MASI ) will no doubt be intrigued by the recent purchase of...
Business WireMasimo Board of Directors Sets the Record Straight on False and Misleading Claims
IRVINE, Calif., June 01, 2023--The Masimo Corporation ("Masimo" or the "Company") (Nasdaq: MASI) Board of Directors today issued a letter to stockholders to set the record straight on the many highly misleading and inaccurate claims recently published by Politan Capital Management ("Politan"). Politan’s reckless and unprincipled willingness to distort the truth in pursuit of its agenda shows its founder and nominee Quentin Koffey is not to be trusted to serve on Masimo’s Board of Directors. The
Business WireMasimo Files Investor Presentation Highlighting Track Record of Success, Compelling Strategy, Responsive Governance Changes and Risks Posed by Quentin Koffey’s Agenda
IRVINE, Calif., May 31, 2023--Masimo Corporation ("Masimo" or the "Company") (Nasdaq: MASI) today filed an investor presentation with the U.S. Securities and Exchange Commission in connection with its Annual Meeting of Stockholders to be held on June 26, 2023. The presentation outlines why the management team and Board of Directors are well-positioned to continue delivering strong returns to all stockholders and details the risk that Politan Capital Management ("Politan") and its nominee Quentin
Business WirePolitan Releases Investor Presentation Detailing Why New Directors Are Needed on the Masimo Board and Responds to Company’s Disingenuous Claims
NEW YORK, May 30, 2023--Politan Capital Management (together with its affiliates, "Politan"), a 9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ: MASI), today released a presentation highlighting why independent oversight and greater accountability are urgently needed on the Masimo Board. Politan also responded to multiple false and misleading claims made by the Company in its recent proxy materials and letter to shareholders.
Business WireMasimo Board of Directors Files Definitive Proxy and Issues Letter to Stockholders
IRVINE, Calif., May 26, 2023--The Masimo Corporation ("Masimo" or the "Company") (Nasdaq: MASI) Board of Directors today issued a letter to stockholders in connection with its definitive proxy materials filed on May 24, 2023, and the Company’s Annual Meeting of Stockholders to be held on June 26, 2023. The letter outlines the management team and Board of Directors’ long track record of creating stockholder value, compelling strategy and responsive governance changes, in addition to detailing the
ZacksZacks Industry Outlook Highlights Hologic, Masimo and Integer
Hologic, Masimo and Integer have been highlighted in this Industry Outlook article.
ZacksMasimo's (MASI) Platform Expansion to Boost Patient Monitoring
Masimo's (MASI) latest expansion to its HEOS platform will likely revolutionize health and wellness tracking by allowing connected care as consumers become tetherless and smartphone-less.
Zacks3 Medical Instruments Stocks to Buy Amid Industry Challenges
The Zacks Medical - Instruments industry is growing on rising demand for digital health. HOLX, MASI and ITGR are set to gain the most. Yet, ongoing inflation, in the form of rising freight and raw material costs, is disrupting the trend.
Business WireMasimo Announces Major Expansion of the HEOS® Platform
IRVINE, Calif., May 24, 2023--The Masimo HEOS® platform is expanding to enable connection to the Masimo secure health cloud for 4 million devices from Denon and other brands.
ZacksDown -16.93% in 4 Weeks, Here's Why Masimo (MASI) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for Masimo (MASI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Business WirePolitan Calls on Shareholders to Elect Independent Oversight to Masimo’s Board
NEW YORK, May 23, 2023--Politan Capital Management (together with its affiliates, "Politan"), a 9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ: MASI), today sent a letter to the Company’s shareholders outlining why independent oversight and greater accountability is urgently needed on the Masimo Board. Politan also filed definitive proxy materials in connection with Masimo’s Annual Meeting of Stockholders (the "Annual Meeting"), which is currently scheduled for June 26,
Zacks3 Reasons to Retain Masimo (MASI) Stock in Your Portfolio
Investors continue to be optimistic about Masimo (MASI) due to its focus on patient monitoring.
Business WireOrange County Business Journal Names Masimo’s Micah Young CFO of the Year
IRVINE, Calif., May 12, 2023--Masimo Chief Financial Officer Micah Young was awarded CFO of the Year by the Orange County Business Journal.
- Simply Wall St.
Does The Market Have A Low Tolerance For Masimo Corporation's (NASDAQ:MASI) Mixed Fundamentals?
It is hard to get excited after looking at Masimo's (NASDAQ:MASI) recent performance, when its stock has declined 8.6...
ZacksMasimo (MASI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Masimo (MASI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
ZacksMasimo (MASI) Q1 Earnings Surpass Estimates, Margins Down
Masimo's (MASI) robust product shipments and continued strength in its healthcare business drive its Q1 sales.
ZacksMasimo (MASI) Beats Q1 Earnings and Revenue Estimates
Masimo (MASI) delivered earnings and revenue surprises of 4.82% and 1.38%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Masimo Reports First Quarter 2023 Financial Results
IRVINE, Calif., May 09, 2023--Masimo (Nasdaq: MASI) today announced its financial results for the first quarter of 2023, ended April 1, 2023.
ZacksIs Fulgent Genetics (FLGT) Stock Outpacing Its Medical Peers This Year?
Here is how Fulgent Genetics, Inc. (FLGT) and Masimo (MASI) have performed compared to their sector so far this year.
Business WireCambridge University Hospitals Expands Virtual Care Program with Masimo W1™
NEUCHATEL, Switzerland, May 08, 2023--The Masimo W1™ advanced health tracking watch is being adopted by Cambridge University Hospitals for use in its telehealth and telemedicine programs.
ZacksEarnings Preview: Masimo (MASI) Q1 Earnings Expected to Decline
Masimo (MASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Business Wire
Politan Nominates Two Candidates for Masimo Board
NEW YORK, May 02, 2023--Politan Capital Management (together with its affiliates, "Politan"), a 9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ: MASI), today announced that it has nominated two candidates for election to the Masimo Board of Directors (the "Board") at the upcoming 2023 Annual Meeting of Stockholders (the "Annual Meeting"), which is currently scheduled for June 26, 2023.
BloombergApple-Masimo Trade Secrets Fight Ends With No Jury Verdict
(Bloomberg) -- Apple Inc. and Masimo Corp. failed to persuade a jury to reach a unanimous verdict in a trial where the medical-devices company claimed a blood-oxygen sensor in the Apple Watch was developed using misappropriated trade secrets.Most Read from BloombergPowell’s Bet Against Recession Looks Good — Minus the Credit Crunch and a DC StandoffTexas Mass Shooting’s Bloody Images Add to Fervor in Gun DebateGoldman to Pay $215 Million to End Case on Underpaying WomenWhy Airfares, Hotels and C
